Tag: Treatment
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with...
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentIn a recent presentation...
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of...
Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024...
Breaking Financial News
Broadcom Stock Surges 13% on Strong Profits and AI Growth Opportunity
Broadcom CEO Hock Tan announced that the company's stock surged by a remarkable 13% following the release of their better-than-expected fourth-quarter earnings. The chipmaker...
